US29014R2022 - Common Stock
ELOXX PHARMACEUTICALS INC
NASDAQ:ELOX (10/13/2023, 7:00:02 PM)
After market: 2.8 -1.02 (-26.7%)3.82
-0.23 (-5.68%)
Eloxx Pharmaceuticals, Inc. engages in the development of novel ribonucleic acid-modulating drug candidates. The company is headquartered in Watertown, Massachusetts and currently employs 18 full-time employees. The company went IPO on 2012-11-23. The firm is engaged in the science of ribosome modulation, leveraging both its TURBO- ZM chemistry technology platform and its library of aminoglycosides to develop oral small-molecule ribosome modulating agents (RMAs) and eukaryotic ribosome selective glycosides (ERSGs) for the treatment of rare and ultra-rare genetic diseases. Its lead investigational product candidate, ELX-02, is a small molecule drug candidate designed to restore production of full-length functional proteins. The firm is also advancing ZKN-013 as an oral agent for the treatment of recessive dystrophic (RDEB)/ junctional epidermolysis bullosa (JEB) and familial adenomatous polyposis (FAP) patients with nonsense mutations. The firm also has preclinical programs focused on select rare diseases, including inherited diseases, cancer caused by nonsense mutations, kidney diseases, as well as rare ocular genetic disorders.
ELOXX PHARMACEUTICALS INC
480 Arsenal Way, Suite 130
Watertown MASSACHUSETTS 02451
P: 17815775300.0
CEO: Gregory C. Williams
Employees: 18
Website: https://www.eloxxpharma.com/
Almirall obtains exclusive global rights to develop and commercialize ZKN-013 for the treatment of rare dermatological and other diseases associated with...
Although getting the boot from an exchange is usually bad news, sometimes there’s a case for delisted stocks to buy.
Kidney morphology improved in all three patients with protein re-expression consistent with disease regression in its Phase 2 open-label clinical trial of...
Here you can normally see the latest stock twits on ELOX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: